Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 32 of 102, showing 5 Applications out of 507 total, starting on record 156, ending on 160

# Protocol No Study Title Investigator(s) & Site(s)

156.

ECCT/11/08/05   Rifapentine During Intensive Phase TB Treatment
        Evaluation of a rifapentine-containing regimen for intensive phase treatment of pulmonary tuberculosis   
Principal Investigator(s)
1. Lena Matata
2. Kevin Cain
Site(s) in Kenya
KEMRI/CDC-KISUMU
 
View

157.

ECCT/15/08/01   Rifapentine During Intensive Phase TB Treatment
     Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: a randomized, open-label, controlled, phase 3 clinical trial   
Principal Investigator(s)
1. Elisha Ochieng Okeyo
Site(s) in Kenya
KEMRICDC, KISUMU, KENYA
 
View

158.

ECCT/25/03/01   MK-5684_MSD (mCRPC)
     A Phase 3, Randomized, Open-label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed On or After Prior Treatment with One Next-generation Hormonal Agent (NHA)    
Principal Investigator(s)
1. PROF MANSOOR NOORALI SALEH
Site(s) in Kenya
AGA KHAN UNIVERSITY HOSPITAL NAIROBI
 
View

159.

ECCT/20/09/02   BEe-HIVe
     B-ENHANCEMENT OF HBV VACCINATIONIN PERSONS LIVING WITH HIV (BEe-HIVe) EVALUATION OF HEPLISAV-B,A5379   
Principal Investigator(s)
1. JOSPHAT KOSGEI
Site(s) in Kenya
KEMRI/KERICHO CLINIC RESEARCH CENTRE
 
View

160.

ECCT/21/02/04   GASTROSAM
     GASTROSAM   Gastroenteritis: Rehydration of children with severe acute malnutrition   
Principal Investigator(s)
1. Professor Kathryn Maitland
Site(s) in Kenya
Kilifi County Hospital
 
View